Long-Acting Injectable Buprenorphine for Birthing and Parenting People with OUD

Friday, April 24, 2026

3:15 PM - 4:30 PM PT

Location: Harbor G-I, Level 2

Presenter(s)

DS

Davida M. Schiff, MD

Associate Professor of Pediatrics
Massachusetts General Hospital
Boston, Massachusetts

Slides
Marcela C. Smid, MD MA MS

Associate professor
University of Utah Health
Salt Lake City, Utah

Slides
Melinda Ramage, FNP-BC, CARN-AP, LCAS

Director, Perinatal Substance Use Disorder Network
Governor's Institute
Asheville, North Carolina

Slides
Vania P. Rudolf, MD, MPH, FAAFP, DFASAM

Faculty Physician, Swedish Medical Center, Seattle, WA
Associate Professor, Department of Family Medicine, University of Washington
Seattle, Washington

Slides
Tricia E. Wright, MD, MS, FACOG, DFASAM

Professor and Medical Director OBIC
University of California, San Francisco
San Francisco, California

Slides

Non-presenting author(s)

Sharon Ostfeld-Johns, MD, IBCLC

Assistant Professor of Clinical Pediatrics and Internal Medicine
Yale School of Medicine
New Haven, Connecticut

Whole-person SUD care approaches health as an integrated spectrum of disease and wellness that is biological, behavioral, environmental, and social; prioritizes the individual, and efforts to address policy and economic level stressors to improve health. Treatment with LAIB formulations supports access, equity, value-based caring and optimal outcomes. Shared-decision making on choices of MOUD, "complex pain" management, toxicology and breastfeeding is a human right. The workshop will highlight opportunities for providers to be a champion for the health of their patients.

Learning Objectives:

Learners will be able to:

Upon completion, participants will be able to describe evidence and results from CTN-0080 MOMs trial, know models of initiation of LAIB, "complex pain" management and longitudinal tools to improve care for birthing people with OUD.
Upon completion, participants will be able to utilize ASAM tools and The 4Th criteria as a holistic guideline tool to offer person-centered care and choices for MOUD for pregnant, postpartum and parenting people with OUD.
Upon completion, participants will be able to apply several concepts to improve skills for clinical care of newborns, utility of toxicology testing, and breastfeeding in the setting of non-prescribed opioid use and LAIB formulations.

Disclosure(s):

Davida M. Schiff, MD: No financial relationships to disclose

Marcela C. Smid, MD MA MS: Gilead Sciences Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Koko Medical Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novocuff: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Melinda Ramage, FNP-BC, CARN-AP, LCAS: No financial relationships to disclose

Vania P. Rudolf, MD, MPH, FAAFP, DFASAM: No financial relationships to disclose

Tricia E. Wright, MD, MS, FACOG, DFASAM: No financial relationships to disclose

Sharon Ostfeld-Johns, MD, IBCLC: No financial relationships to disclose